R.L. Edwards is associate vice president, Health System Administration, and chief external affairs officer, UK HealthCare, Lexington, Kentucky. M.D. Birdwhistell is vice president, Health System Administration, UK HealthCare, Lexington, Kentucky. J.W. Zembrodt is associate vice president, Enterprise Strategy, UK HealthCare, Lexington, Kentucky. M.F. Newman is executive vice president, Health Affairs, University of Kentucky, Lexington, Kentucky. M. Karpf is advisor to the president, professor of medicine, and former executive vice president, Health Affairs, University of Kentucky, Lexington, Kentucky.
Acad Med. 2019 Dec;94(12):1895-1902. doi: 10.1097/ACM.0000000000002878.
Over the last 15 years, UK HealthCare, the clinical enterprise of the University of Kentucky, has undertaken 3 clinical strategic plans to secure its position as a research-intensive, referral academic medical center. The first plan, titled Securing the Traditional Marketplace (2005-2010), focused on building advanced subspecialty programs on campus while pursuing partnerships with providers in UK HealthCare's traditional marketplace, eastern Kentucky. The second plan, Expanding the Footprint (2010-2015), recognized that UK HealthCare needed to cover a population base of 5 to 10 million people to support its subspecialty programs. These 2 strategic plans were successful and achieved 4 outcomes: a doubling of annual discharges, a dramatic increase of transfers/external referrals, a significant increase in the case mix index, and impressive growth in subspecialty programs. The third clinical strategic plan, Preparing for Change (2015-2020), has expanded UK HealthCare's gains in the face of rapidly changing reimbursement systems and delivery models. The pillars of this plan are responding to consumerism, strengthening hallmark programs through service lines, "hard wiring" relationships with partnering organizations including establishing the Kentucky Health Collaborative, and building infrastructure to deal with risk-based reimbursement. UK HealthCare is trying to spearhead a rational system of care for Kentucky rather than a system that rations care. Halfway through the third clinical strategic plan, UK HealthCare has seen increased discharges, transfers, and clinical expansion in its hallmark programs, building evidence that well-thought business practices can lead to improved public policy.
在过去的 15 年里,肯塔基大学的临床机构 UK HealthCare 实施了 3 个临床战略计划,以确保其作为研究密集型转诊学术医疗中心的地位。第一个计划名为“确保传统市场地位”(2005-2010 年),专注于在校园内建立先进的亚专科项目,同时寻求与 UK HealthCare 传统市场(肯塔基州东部)的提供商建立合作关系。第二个计划名为“扩大足迹”(2010-2015 年),认识到 UK HealthCare 需要覆盖 500 万至 1000 万人口,以支持其亚专科项目。这两个战略计划都取得了成功,并实现了以下 4 个结果:每年出院人数翻了一番,转院/外部转诊大幅增加,病例组合指数显著提高,亚专科项目显著增长。第三个临床战略计划名为“为变革做准备”(2015-2020 年),在面对快速变化的报销系统和交付模式时,扩大了 UK HealthCare 的收益。该计划的支柱是应对消费主义,通过服务线加强标志性项目,“硬连线”与合作伙伴组织的关系,包括建立肯塔基健康合作组织,并建立基础设施来应对基于风险的报销。UK HealthCare 试图为肯塔基州带头建立一个合理的医疗保健系统,而不是一个限制医疗保健的系统。在第三个临床战略计划实施到一半时,UK HealthCare 已经看到其标志性项目的出院人数、转院人数和临床扩张有所增加,这表明深思熟虑的商业实践可以带来改善的公共政策。